Nonalcoholic steatohepatitis (NASH ... This article will briefly discuss prevalence studies and the pathophysiology of NAFLD and focus on current discussions related to the specific lesions ...

Metabolic dysfunction-associated steatohepatitis (MASH ... A key factor in the pathology of MASH is the disruption of ...

More information: Rui Zuo et al, Ablation of Hepatic Asah1 Gene Disrupts Hepatic Lipid Homeostasis and Promotes Fibrotic Nonalcoholic Steatohepatitis in Mice, The American Journal of Pathology (2024).

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

People with MASLD and more so with metabolic dysfunction-associated steatohepatitis (MASH ... MASLD is a heterogeneous disease regarding its pathophysiology and clinical outcomes.

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated with significant global ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted full qualification for ...

Histoindex Pte Ltd. launched its laboratory-developed test for metabolic dysfunction-associated steatohepatitis (MASH), ...

The biopsy findings of cirrhotic NAFLD and NASH are another area of investigation in pathology ... retain diagnostic histopathologic features of steatohepatitis in follow-up biopsy, which provides ...